229 related articles for article (PubMed ID: 17665991)
1. The versatility of oligonucleotides as potential therapeutics.
Eckstein F
Expert Opin Biol Ther; 2007 Jul; 7(7):1021-34. PubMed ID: 17665991
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic oligonucleotides.
Goodchild J
Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
[TBL] [Abstract][Full Text] [Related]
3. [Oligonucleotide therapeutics - an emerging novel class of compounds].
Wacheck V
Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
[TBL] [Abstract][Full Text] [Related]
4. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
5. Ribozymes, DNAzymes and small interfering RNAs as therapeutics.
Sioud M; Iversen PO
Curr Drug Targets; 2005 Sep; 6(6):647-53. PubMed ID: 16178798
[TBL] [Abstract][Full Text] [Related]
6. RNA-based therapeutics: current progress and future prospects.
Burnett JC; Rossi JJ
Chem Biol; 2012 Jan; 19(1):60-71. PubMed ID: 22284355
[TBL] [Abstract][Full Text] [Related]
7. Antisense technologies. Improvement through novel chemical modifications.
Kurreck J
Eur J Biochem; 2003 Apr; 270(8):1628-44. PubMed ID: 12694176
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
Nakata Y; Kim TK; Shetzline S; Gewirtz AM
Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
[TBL] [Abstract][Full Text] [Related]
9. DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.
Fokina AA; Stetsenko DA; François JC
Expert Opin Biol Ther; 2015 May; 15(5):689-711. PubMed ID: 25772532
[TBL] [Abstract][Full Text] [Related]
10. Oligomeric nucleic acids as antivirals.
Mescalchin A; Restle T
Molecules; 2011 Jan; 16(2):1271-96. PubMed ID: 21278679
[TBL] [Abstract][Full Text] [Related]
11. Frontiers in nucleic acid-based drug research and development.
Sun LQ; Wong JP
Future Med Chem; 2015; 7(13):1619-21. PubMed ID: 26465712
[No Abstract] [Full Text] [Related]
12. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
13. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
14. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.
Bhindi R; Fahmy RG; Lowe HC; Chesterman CN; Dass CR; Cairns MJ; Saravolac EG; Sun LQ; Khachigian LM
Am J Pathol; 2007 Oct; 171(4):1079-88. PubMed ID: 17717148
[TBL] [Abstract][Full Text] [Related]
15. Nucleic-acid therapeutics: basic principles and recent applications.
Opalinska JB; Gewirtz AM
Nat Rev Drug Discov; 2002 Jul; 1(7):503-14. PubMed ID: 12120257
[TBL] [Abstract][Full Text] [Related]
16. Catalytic DNA: a novel tool for gene suppression.
Cairns MJ; Saravolac EG; Sun LQ
Curr Drug Targets; 2002 Jun; 3(3):269-79. PubMed ID: 12041740
[TBL] [Abstract][Full Text] [Related]
17. DNAzymes as potential therapeutic molecules.
Isaka Y
Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
[TBL] [Abstract][Full Text] [Related]
18. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.
Spurgers KB; Sharkey CM; Warfield KL; Bavari S
Antiviral Res; 2008 Apr; 78(1):26-36. PubMed ID: 18258313
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.
Lavrovsky Y; Chen S; Roy AK
Biochem Mol Med; 1997 Oct; 62(1):11-22. PubMed ID: 9367793
[TBL] [Abstract][Full Text] [Related]
20. RNA Therapeutics: How Far Have We Gone?
Coutinho MF; Matos L; Santos JI; Alves S
Adv Exp Med Biol; 2019; 1157():133-177. PubMed ID: 31342441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]